Menu Search
Equities

Kaneka Corp

4118:DEU

Kaneka Corp

Actions
  • Price (EUR)20.40
  • Today's Change0.40 / 2.00%
  • Shares traded0.00
  • 1 Year change-9.73%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KANEKA CORPORATION is a Japan-based company engaged in four business segments. The Material Solutions Unit segment includes general purpose vinyl chloride resin, caustic soda, polyvinyl chloride special resin, modifier, modified silicone polymer, biodegradable polymer. Quality of Life Solutions Unit segment includes expanded styrene resin and molded products, extruded polystyrene foam boards, bead method expanded polyolefin, solar circuit method, super heat resistant polyimide films, optical materials, super heat conductive graphite sheets, solar cells, storage batteries for housing and others. The Health Care Solutions Unit segment includes medical devices, low molecular weight pharmaceutical raw materials, biopharmaceuticals, etc. The Nutrition Solutions Unit segment includes functional food ingredients, margarine, shortening, baker's yeast, spices, antifreeze ingredients, functional fertilizers and feeds.

  • Revenue in JPY (TTM)788.15bn
  • Net income in JPY24.49bn
  • Incorporated1949
  • Employees11.54k
  • Location
    Kaneka CorpNakanoshima Festival Tower2-3-18, Nakanoshima, Kita-kuOSAKA-SHI 530-8288JapanJPN
  • Phone+81 662265050
  • Fax+81 662265037
  • Websitehttps://www.kaneka.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		4118:TYO since
announced		Transaction
value
Japan Medical Device Technology Co LtdDeal completed30 Nov 202330 Nov 2023Deal completed-6.50%--
Data delayed at least 20 minutes, as of Nov 25 2024 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.